Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Diplopia | Diplopia | x | x | ||
| Dizziness | Dizziness | x | x | ||
| Somnolence | Drowsiness | x | x | ||
| Headache | Headache | x | x | ||
| Haemorrhage | Haemorrhage | x | |||
| Haemoglobin | Haemorrhage | x | |||
| Hyperventilation | Hyperventilation | x | x | ||
| Inflammation | Inflammation | x | |||
| Nausea | Nausea | x | x | ||
| Pain | Pain | x | x | ||
| Tachycardia | Tachycardia | x | x | ||
| Muscular weakness | Muscular weakness | x | |||
| Agitation | Excitement | x | x | ||
| Muscle necrosis | Muscle necrosis | x | |||
| Vision blurred | Vision blurred | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |